Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis A Eichenauer

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
Hemasphere|January 17, 2020
Introducing the HemaSphere Controversies SeriesDennis A Eichenauer, Jan Cools, Andreas Engert
Oncotargets and Therapy|July 10, 2010
Expanded use of rituximab in the management of non-Hodgkin lymphomaDennis A Eichenauer, Andreas Engert, Holger Schulz
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|October 26, 2021
[Hemophagocytic lymphohistiocytosis in critically ill patients]Dennis A Eichenauer, Gunnar Lachmann, Paul La Rosée
Hematological Oncology|June 15, 2025
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and TreatmentPeter Borchmann, Dennis A Eichenauer, Gerard Frigola, et al.
Expert Review of Hematology|November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approachesDennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
British Journal of Haematology|February 6, 2014
Current status of prognostication in classical Hodgkin lymphomaGirish Venkataraman, M Kamran Mirza, Dennis A Eichenauer, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Nodular lymphocyte-predominant Hodgkin lymphomaMichael Fuchs, Dennis A Eichenauer, Lucia Nogová, et al.
Journal of Palliative Medicine|September 30, 2024
Hospital Palliative Care Team Involvement in Inpatients with Hematologic Malignancies: A Retrospective StudyAnja M Caspers, Dennis A Eichenauer, Anne Pralong, et al.
The Cochrane Database of Systematic Reviews|September 14, 2017
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysisJeremy Franklin, Dennis A Eichenauer, Ingrid Becker, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Nature Reviews. Clinical Oncology|June 13, 2012
State of the art in the treatment of Hodgkin lymphomaPeter Borchmann, Dennis A Eichenauer, Andreas Engert
Hemasphere|January 17, 2020
Introducing the HemaSphere Controversies SeriesDennis A Eichenauer, Jan Cools, Andreas Engert
Oncotargets and Therapy|July 10, 2010
Expanded use of rituximab in the management of non-Hodgkin lymphomaDennis A Eichenauer, Andreas Engert, Holger Schulz
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|October 26, 2021
[Hemophagocytic lymphohistiocytosis in critically ill patients]Dennis A Eichenauer, Gunnar Lachmann, Paul La Rosée
Hematological Oncology|June 15, 2025
Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Update on Biology and TreatmentPeter Borchmann, Dennis A Eichenauer, Gerard Frigola, et al.
Expert Review of Hematology|November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approachesDennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
British Journal of Haematology|February 6, 2014
Current status of prognostication in classical Hodgkin lymphomaGirish Venkataraman, M Kamran Mirza, Dennis A Eichenauer, et al.
Current Hematologic Malignancy Reports|April 29, 2010
Nodular lymphocyte-predominant Hodgkin lymphomaMichael Fuchs, Dennis A Eichenauer, Lucia Nogová, et al.
Journal of Palliative Medicine|September 30, 2024
Hospital Palliative Care Team Involvement in Inpatients with Hematologic Malignancies: A Retrospective StudyAnja M Caspers, Dennis A Eichenauer, Anne Pralong, et al.
The Cochrane Database of Systematic Reviews|September 14, 2017
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysisJeremy Franklin, Dennis A Eichenauer, Ingrid Becker, et al.
Pageof 13